Thank you for the charts & input mate, everyone charting for that matter
@FreedomInvestorWe just may get that news shortly your talking of.
If the patent regarding 'cell manufacturing' is as good we believe it will be than a massive re-rate could be on the cards.
I know that any IP in biotech that can be monetised immediately is BIG news...So if we can licence the technique out to companies involved in cell therapies that this could be a fairly big deal for PTX.
Only being about $120m MC, it wouldn't suprise me if we doubled over the coming months off the back of IP that can generate revenue, it's significantly de-risking.
Of course we need to see the unveiling of the 'Stealth Program' before we count our chickens but the current chart movements is making perfect sense to me knowing what's potentially about to be released...Someone was kind enough to post a medical paper from a few months back regarding exciting new cell manufacturing techniques, I believe Peter MacCallum were involved in the paper and the crux of it sounded exactly like our patent about to drop.
Exciting times.
